Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
2.
J Air Waste Manag Assoc ; 51(11): 1561-7, 2001 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-11720103

RESUMO

Anomalies appear to exist in our understanding of atmospheric sulfur compounds, specifically as evidenced in the time trends of the different chemical forms of these compounds. Trends determined at a number of locations by several different groups seem to indicate that, responding to emission reductions across North America, the concentration of SO2 in the atmosphere is declining more rapidly than that of aerosol SO4(2-). A number of possible reasons for this discrepancy are examined, but it is not possible to provide a definitive answer at this stage. The intent is to stimulate debate, because shortcomings in our understanding of the processes involved could have profound implications for the credibility of abatement strategies and policies for both acid deposition and fine particulate matter (PM).


Assuntos
Poluentes Atmosféricos/análise , Poluição do Ar/prevenção & controle , Compostos de Enxofre/química , Chuva Ácida , Aerossóis , Monitoramento Ambiental , Política Pública , Compostos de Enxofre/análise , Dióxido de Enxofre/química , Ácidos Sulfúricos/química
3.
Leuk Res ; 25(10): 891-900, 2001 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-11532523

RESUMO

Cyclopentenyl cytosine (CPEC) is a nucleoside-analogue that decreases the concentrations of cytidine triphosphate (CTP) and deoxycytidine triphosphate (dCTP) in leukemic cells by inhibiting the enzyme CTP synthetase, resulting in a decreased synthesis of RNA and DNA. Low concentrations of dCTP facilitate the phosphorylation of 1-beta-D arabinofuranosyl cytosine (araC) and the incorporation of arabinofuranosyl cytosine triphosphate (araCTP) into DNA. Apoptosis and necrosis were analyzed by flow cytometric detection of fluorescence-labeled Annexin V in a human T-lymphoblastic MOLT-3 cell-line after incubations with CPEC and/or araC. CPEC induced apoptosis and necrosis in a concentration- (50-300 nM) and time-dependent (8-16 h) way. The observed necrosis proved to be secondary to apoptosis as the caspase inhibitor benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone (zVAD-fmk) completely blocked the CPEC-induced apoptosis and necrosis. Coincubation of various concentrations of CPEC and araC for 16h showed a significant additive effect on the occurrence of apoptosis and (secondary) necrosis. In contrast, a preincubation with 37.5 nM of CPEC for 24 h, which by itself caused only minor apoptosis (4%), followed by a coincubation for 16 h with 62.5 nM of araC (7% of apoptotic cells), showed a synergistic effect on the induction of apoptosis (27%, P<0.001). Growth-inhibition experiments with CPEC and araC under various conditions showed an additive effect on the araC-induced growth-inhibition after 48 h. The results indicate that the cytotoxicity of araC can be increased in T-lymphoblasts by CPEC.


Assuntos
Antimetabólitos Antineoplásicos/farmacologia , Antineoplásicos/farmacologia , Apoptose/efeitos dos fármacos , Citarabina/farmacologia , Citidina/farmacologia , Leucemia de Células T/tratamento farmacológico , Células Tumorais Cultivadas/efeitos dos fármacos , Anexina A5/metabolismo , Divisão Celular/efeitos dos fármacos , Citidina/análogos & derivados , Relação Dose-Resposta a Droga , Sinergismo Farmacológico , Humanos , Leucemia de Células T/metabolismo , Leucemia de Células T/patologia , Necrose
4.
Br J Haematol ; 114(1): 126-33, 2001 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-11472357

RESUMO

Thrombopoietin (Tpo), the main regulator of thrombocytopoiesis, is a probable candidate to play a role in the increase in platelet counts that is frequently seen after surgery. In the current study, serial blood samples of patients that underwent major surgery were analysed with respect to Tpo kinetics, platelet turnover and inflammatory cytokines. Platelet Tpo content and plasma Tpo levels rose before platelet counts increased, suggesting that Tpo was indeed responsible for the elevation in platelet counts. In addition, an increase in interleukin 6 (IL-6) levels, but not in IL-11 and tumour necrosis factor alpha levels, was seen before the rise in Tpo concentration. In vitro, IL-6 was shown to enhance Tpo production by the HepG2 liver cell line. Thus, increased Tpo levels after surgery, possibly resulting from enhanced Tpo production under the influence of IL-6 or other inflammatory cytokines, are involved in an enhanced thrombocytopoiesis.


Assuntos
Interleucina-6/análise , Complicações Pós-Operatórias/sangue , Trombocitose/sangue , Trombopoetina/sangue , Idoso , Artroplastia de Quadril , Artroplastia do Joelho , Plaquetas/química , Linhagem Celular , Células Cultivadas , Ponte de Artéria Coronária , Feminino , Humanos , Interleucina-6/farmacologia , Fígado/efeitos dos fármacos , Fígado/metabolismo , Masculino , Pessoa de Meia-Idade , Contagem de Plaquetas , Trombopoetina/análise
5.
Br J Haematol ; 91(1): 55-9, 1995 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-7577652

RESUMO

In this paper we describe a new, rapid and sensitive method to determine plasma cell isotype and clonality in bone marrow using flowcytometry. With the use of a new fixation and permeabilization reagent (Permeafix), which preserves cell structure and morphology, and a monoclonal antibody (Mab) specific for plasma cells (B-B4), it has become possible to specifically select plasma cells and to determine the cytoplasmatic immunoglobulins by flowcytometry. Thirty successive bone marrow aspirates from multiple myeloma patients and patients with MGUS were studied as well as 10 bone marrow samples from patients with reactive plasmacytosis. Each sample was analysed both by immunofluorescence on cytospin smears and FACS analysis. There were no discrepancies between plasma cell isotype as determined by FACS and cytospin. Moreover, FACS analysis was shown to allow detection of very low numbers of plasma cells and to determine whether these plasma cells are mono- or polyclonal. Possible applications are discussed.


Assuntos
Medula Óssea/imunologia , Isotipos de Imunoglobulinas/análise , Imunofenotipagem/métodos , Plasmócitos/imunologia , Anticorpos , Contagem de Células , Células Clonais/imunologia , Citoplasma/imunologia , Fixadores , Citometria de Fluxo , Humanos , Mieloma Múltiplo/patologia
6.
J Lab Clin Med ; 100(5): 720-34, 1982 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-7130829

RESUMO

ESF titers were determined in 99 patients of various stages of chronic renal failure, by using the fetal mouse liver cell bioassay. Of these patients 45 were receiving conservative therapy and 54 on maintenance hemodialysis. ESF levels were significantly below normal in both groups of patients. A significant inverse relationship was found between hemoglobin concentration and ESF level in the predialysis patients with chronic glomerulonephritis. No correlation was found between both parameters in the predialysis patients with chronic nonglomerular renal disease. A significant positive correlation was found between hemoglobin concentration and ESF level in nephric dialysis patients who were transfusion independent. Transfusion-dependent nephric dialysis patients had lower hemoglobin concentrations and lower ESF levels before transfusion than did nephric dialysis patients who were transfusion independent. In nephric dialysis patients ESF levels fell sharply after blood transfusion, whereas in anephric dialysis patients such a physiologic ESF response was not found. It was concluded that despite the presence of an absolute ESF deficiency in all anemia uremic patients, this anemia cannot be explained by ESF deficiency alone. The increasing degree of anemia found in predialysis patients with deteriorating renal function appears to be primarily caused by factors other than ESF deficiency, the most likely being accumulation of uremic inhibitors of erythropoiesis. In dialysis patients in whom inhibitor levels are relatively homogeneous, the degree of anemia appears to be directly related to the residual capability of the kidney or the extrarenal sites to produce ESF.


Assuntos
Anemia/sangue , Eritropoetina/sangue , Falência Renal Crônica/sangue , Adulto , Idoso , Anemia/etiologia , Creatinina/metabolismo , Feminino , Hemoglobinas/análise , Humanos , Falência Renal Crônica/complicações , Masculino , Pessoa de Meia-Idade , Diálise Renal
7.
Blood ; 58(6): 1164-70, 1981 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-7306704

RESUMO

Erythropoietin (ESF) titers were determined in sera from patients with different types of anemia using the fetal mouse liver cell bioassay. An inverse relationship was found between hemoglobin concentration and ESF titer. However, ESF titers differed markedly between patients at comparable degrees of anemia. Several groups of patients were distinguished on the basis of the activity of their erythroid bone marrow. In each of these groups, a significant negative correlation was found between the hemoglobin concentration and the logarithm of the ESF titer. ESF titers in patients with pure red cell aplasia were fourfold higher than those in patients with iron-deficiency anemia and tenfold higher than those in patients with megaloblastic anemia and homozygous sickle cell anemia at comparable hemoglobin concentrations. Following the initiation of specific therapy in patients with pernicious anemia and patients wit iron-deficiency anemia, serum ESF titers were found to decrease prior to any substantial rise in hemoglobin concentrations. In the patients with pernicious anemia, the lowest ESF levels were found 1 day after administration of vitamin B12, whereas in the patients with iron-deficiency anemia, the lowest ESF levels were reached in the second week of oral iron therapy. ON the basis of these data it was concluded that serum ESF titers in anemic patients are not only inversely related to the hemoglobin concentration but also to the activity of the erythroid bone marrow.


Assuntos
Anemia/sangue , Eritropoetina/sangue , Anemia Hipocrômica/tratamento farmacológico , Anemia Perniciosa/sangue , Anemia Perniciosa/tratamento farmacológico , Animais , Células da Medula Óssea , Contagem de Eritrócitos , Feminino , Hemoglobinas , Humanos , Ferro/uso terapêutico , Camundongos , Camundongos Endogâmicos , Gravidez , Reticulócitos , Vitamina B 12/uso terapêutico
8.
Blood ; 58(6): 1171-4, 1981 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-7306705

RESUMO

Serum ESF titers were measured in 42 polycythemic patients using the fetal mouse liver cell bioassay. ESF titers in patients with secondary polycythemia differed significantly from those in patients with polycythemia vera (p less than 0.0001). Among the 21 patients with secondary polycythemia, 1 patient had an ESF titer less than 10 mU/ml (the lower limit of sensitivity) and 20 had ESF titers that ranged between 11 and 112 mU/ml, with a mean titer of 56 mU/ml. Among the 21 patients with polycythemia vera, 13 patients had ESF titers less than 10 mU/ml and 8 had ESF titers ranging between 12 and 55 mU/ml, with a mean titer of 26 mU/ml. The mean hemoglobin concentration in the 8 patients with ESF titers greater than 10 mU/ml was significantly below that in the 13 polycythemia vera patients with ESF titers less than 10 mU/ml (p less than 0.03). If ESF titers less than 10 mU/ml had been indicative of polycythemia vera and ESF titers greater than 10 mU/ml had been indicative of secondary polycythemia in patients with hemoglobin concentrations greater than 17.7 g/dl, but not indicative of either condition in patients with hemoglobin concentrations less than 17.7 g/dl, 71.5% of the polycythemic patients in this study would have been diagnosed correctly, 9.5% incorrectly, and in the 19% the diagnosis would have remained uncertain. It was concluded that measurement of serum ESF titers using this in vitro bioassay can be of clinical importance in differentiating between polycythemia vera and secondary polycythemia.


Assuntos
Eritropoetina/biossíntese , Policitemia Vera/sangue , Adulto , Idoso , Animais , Hematócrito , Hemoglobinas , Humanos , Fígado/análise , Camundongos , Camundongos Endogâmicos , Pessoa de Meia-Idade , Policitemia/sangue , Policitemia/diagnóstico , Policitemia Vera/diagnóstico
9.
Blood ; 55(6): 955-9, 1980 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-7378585

RESUMO

The commercially available hemagglutination inhibition (HAI) assay kit for erythropoietin (ESF) was compared with the fetal mouse liver cell (FMLC) bioassay. No correlation was obtained ESF levels determined by both methods in a variety of pathologic sera. The HAI kit showed a great batch variability. Significant immunoreactivity was found in those fractions of a normal human serum and a human urinary ESF preparation that were not active in the FMLC bioassay. A very poor recovery of immunoreactivity was found when the international reference preparation for erythropoietin (second IRPE) was added to a normal human serum.


Assuntos
Eritropoetina , Fígado/citologia , Absorção , Anemia/sangue , Animais , Eritropoetina/imunologia , Feminino , Testes de Inibição da Hemaglutinação , Humanos , Camundongos , Gravidez , Ovinos , Uremia/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA